NCT06057467View on ClinicalTrials.gov

Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF

NARecruitingINTERVENTIONAL
Enrollment

2,351

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

January 1, 2026

Conditions
Acute Ischemic StrokeAtrial Fibrillation
Interventions
DRUG

Anticoagulation Agents

Anticoagulation agents includes rivaroxaban, dabigatran, apixaban, and edoxaban.

Trial Locations (2)

Unknown

RECRUITING

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

RECRUITING

Jiaxing Second Hospital, Jiaxing

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER